According to Nymox Pharmaceutical's latest financial reports and stock price the company's current number of shares outstanding is 91,265,140. At the end of 2023 the company had 91,265,140 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 91.26 M | 1.67% |
2022 | 89.76 M | 6.07% |
2021 | 84.62 M | 9.56% |
2020 | 77.24 M | 10.52% |
2019 | 69.89 M | 9.26% |
2018 | 63.96 M | 15.27% |
2017 | 55.49 M | 14.81% |
2016 | 48.33 M | 30.62% |
2015 | 37 M | 3.51% |
2014 | 35.74 M | 3.41% |
2013 | 34.57 M | 3.64% |
2012 | 33.35 M | 1.28% |
2011 | 32.93 M | 1.47% |
2010 | 32.45 M | 4.16% |
2009 | 31.15 M | 3.67% |
2008 | 30.05 M | 2.53% |
2007 | 29.31 M | 11.47% |
2006 | 26.29 M | 6.48% |
2005 | 24.69 M | -3.2% |
2004 | 25.51 M | -2.88% |
2003 | 26.27 M | 14.81% |
2002 | 22.88 M | 5.65% |
2001 | 21.65 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 2,537.59% | ๐บ๐ธ USA |
Pfizer PFE | 5,647,000,000 | 6,087.47% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 1,734,076,358 | 1,800.04% | ๐บ๐ธ USA |
Eli Lilly LLY | 949,379,000 | 940.24% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | 112,000,000 | 22.72% | ๐บ๐ธ USA |